论文部分内容阅读
择我院2014年1月~2014年12月收治的138例糖尿病患者均预先采用预混胰岛素,后为提高治疗效果,再转换为甘精胰岛素联合口服降糖药物后血糖控制,对比转换前后患者的各类血糖指标值,分析不同胰岛素治疗方法的应用效果;结果:转换后,患者空腹血糖、餐后2h血糖、平均血糖、糖化血红蛋白等值都明显低于转换前,差异具有统计学意义(P<0.05)。结论:预混胰岛素的依从性较差、治疗效果很难控制,甘精胰岛素联合口服降糖药物可在短时间内维持、恢复各项血糖指标,且安全性非常高,具有临床研究与推广价值。
Choose our hospital from January 2014 to December 2014 were treated 138 cases of diabetic patients were pre-mixed insulin, then to improve the therapeutic effect, and then converted to glargine combined oral glucose-lowering drugs after oral glucose control, before and after the conversion of patients Results: After conversion, the fasting blood glucose, postprandial 2h blood glucose, mean blood glucose, glycosylated hemoglobin and other values were significantly lower than before conversion, the difference was statistically significant ( P <0.05). Conclusion: The compliance of premixed insulin is poor, and the curative effect is difficult to control. Glargine and oral hypoglycemic drugs can maintain and recover various blood sugar indexes in a short time, and the safety is very high. It has the value of clinical research and promotion .